Pharmacy Department, Faculty of Health Sciences, UIN Syarif Hidayatullah Jakarta

Editorial Policies

Focus and Scope

The journal includes various fields of Pharmacy,  pharmaceuticals  and biomedical sciences such as:

Pharmacology and Toxicology

Pharmacokinetics

Community and Clinical Pharmacy

Pharmaceutical Chemistry

Pharmaceutical Biology

Pharmaceutics

Pharmaceutical Technology

Biopharmaceutics

Pharmaceutical Microbiology and Biotechnology

Alternative medicines

Biochemistry

Biomedis

Section Policies

Articles

  • Checked Open Submissions
  • Checked Indexed
  • Checked Peer Reviewed

Peer Review Process

All submitted papers are put through the double-blind review process. The journal accepts both research and non-research articles, which will be peer-reviewed by at least 2 (two) reviewers. Once a manuscript is submitted through the online process, a journal editor examines the manuscript and determines its appropriateness for the full peer review. If it passes the initial screening, the manuscript will be sent to one or more peer reviewers. The journal editorial board will then consider the peer reviewers reports and assemble the final decision to accept or reject the manuscript for publication.

Publication Frequency

Pharmaceutical And Biomedical Sciences Journal (PBSJ) is published twice a year, in June and December. 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author. This is in accordance with Budapest Open Access Initiative

/public/site/images/azki/index_176

Budapest Open Access Initiative

An old tradition and a new technology have converged to make possible an unprecedented public good. The old tradition is the willingness of scientists and scholars to publish the fruits of their research in scholarly journals without payment, for the sake of inquiry and knowledge. The new technology is the internet. The public good they make possible is the world-wide electronic distribution of the peer-reviewed journal literature and completely free and unrestricted access to it by all scientists, scholars, teachers, students, and other curious minds. Removing access barriers to this literature will accelerate research, enrich education, share the learning of the rich with the poor and the poor with the rich, make this literature as useful as it can be, and lay the foundation for uniting humanity in a common intellectual conversation and quest for knowledge.

For various reasons, this kind of free and unrestricted online availability, which we will call open access, has so far been limited to small portions of the journal literature. But even in these limited collections, many different initiatives have shown that open access is economically feasible, that it gives readers extraordinary power to find and make use of relevant literature, and that it gives authors and their works vast and measurable new visibilityreadership, and impact. To secure these benefits for all, we call on all interested institutions and individuals to help open up access to the rest of this literature and remove the barriers, especially the price barriers, that stand in the way. The more who join the effort to advance this cause, the sooner we will all enjoy the benefits of open access.

The literature that should be freely accessible online is that which scholars give to the world without expectation of payment. Primarily, this category encompasses their peer-reviewed journal articles, but it also includes any unreviewed preprints that they might wish to put online for comment or to alert colleagues to important research findings. There are many degrees and kinds of wider and easier access to this literature. By "open access" to this literature, we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited.

While the peer-reviewed journal literature should be accessible online without cost to readers, it is not costless to produce. However, experiments show that the overall costs of providing open access to this literature are far lower than the costs of traditional forms of dissemination. With such an opportunity to save money and expand the scope of dissemination at the same time, there is today a strong incentive for professional associations, universities, libraries, foundations, and others to embrace open access as a means of advancing their missions. Achieving open access will require new cost recovery models and financing mechanisms, but the significantly lower overall cost of dissemination is a reason to be confident that the goal is attainable and not merely preferable or utopian.

To achieve open access to scholarly journal literature, we recommend two complementary strategies.

I. Self-Archiving: First, scholars need the tools and assistance to deposit their refereed journal articles in open electronic archives, a practice commonly called, self-archiving. When these archives conform to standards created by the Open Archives Initiative, then search engines and other tools can treat the separate archives as one. Users then need not know which archives exist or where they are located in order to find and make use of their contents.

II. Open-access Journals: Second, scholars need the means to launch a new generation of journals committed to open access, and to help existing journals that elect to make the transition to open access. Because journal articles should be disseminated as widely as possible, these new journals will no longer invoke copyright to restrict access to and use of the material they publish. Instead they will use copyright and other tools to ensure permanent open access to all the articles they publish. Because price is a barrier to access, these new journals will not charge subscription or access fees, and will turn to other methods for covering their expenses. There are many alternative sources of funds for this purpose, including the foundations and governments that fund research, the universities and laboratories that employ researchers, endowments set up by discipline or institution, friends of the cause of open access, profits from the sale of add-ons to the basic texts, funds freed up by the demise or cancellation of journals charging traditional subscription or access fees, or even contributions from the researchers themselves. There is no need to favor one of these solutions over the others for all disciplines or nations, and no need to stop looking for other, creative alternatives.


Open access to peer-reviewed journal literature is the goal. Self-archiving (I.) and a new generation of open-access journals (II.) are the ways to attain this goal. They are not only direct and effective means to this end, they are within the reach of scholars themselves, immediately, and need not wait on changes brought about by markets or legislation. While we endorse the two strategies just outlined, we also encourage experimentation with further ways to make the transition from the present methods of dissemination to open access. Flexibility, experimentation, and adaptation to local circumstances are the best ways to assure that progress in diverse settings will be rapid, secure, and long-lived.

The Open Society Institute, the foundation network founded by philanthropist George Soros, is committed to providing initial help and funding to realize this goal. It will use its resources and influence to extend and promote institutional self-archiving, to launch new open-access journals, and to help an open-access journal system become economically self-sustaining. While the Open Society Institute's commitment and resources are substantial, this initiative is very much in need of other organizations to lend their effort and resources.

We invite governments, universities, libraries, journal editors, publishers, foundations, learned societies, professional associations, and individual scholars who share our vision to join us in the task of removing the barriers to open access and building a future in which research and education in every part of the world are that much more free to flourish.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

Plagiarism Policy

Pharmaceutical and Biomedical Sciences Journal (PBSJ) recognizes that plagiarism is not acceptable for all author and therefore establishes the following policy stating specific actions (penalties) when plagiarism is identified by  Pharmaceutical and Biomedical Sciences Journal (PBSJ) anti-plagiarism software detection (we are using turnitin.com )  in an article that is submitted for publication. The article must below 25% of plagiarism

 “Plagiarism is copying another person’s text or ideas and passing the copied material as your own work. You must both delineate (i.e., separate and identify) the copied text from your text and give credit to (i.e., cite the source) the source of the copied text to avoid accusations of plagiarism.  Plagiarism is considered fraud and has potentially harsh consequences including loss of job, loss of reputation, and the assignation of reduced or failing grade in a course."
 
This definition of plagiarism applies for copied text and ideas:
 1. Regardless of the source of the copied text or idea.
 2. Regardless of whether the author(s) of the text or idea which you have copied actually copied that  text or idea from another source.
 3. Regardless of whether or not the authorship of the text or idea which you copy is known
 4. Regardless of the nature of your text (journal paper/article, web page, book chapter, paper submitted for a college course, etc) into which you copy the text or idea
 5. Regardless of whether or not the author of the source of the copied material gives permission for the material to be copied; and
 6.  Regardless of whether you are or are not the author of the source of the copied text or idea (self-plagiarism).
 
When plagiarism is identified by the Plagiarism Checker  software,  the Editorial Board responsible for the review of this paper and will agree on measures according to the extent of plagiarism detected in the article in agreement with the following guidelines:
 
Minor Plagiarism
A small sentence or short paragraph of another manuscript is plagiarized without any significant data or idea taken from the other papers or publications.
Punishment: A warning is given to the authors and a request to change the manuscript and properly cite the original sources.
 
Intermediate Plagiarism
A significant data, paragraph, or sentence of an article is plagiarized without proper citation to the original source.
Punishment: The submitted article is automatic rejected.
 
Severe Plagiarism
A large portion of an article is plagiarized that involves many aspects such as reproducing original results (data, formulation, equation, law, statement, etc.), ideas, and methods presented in other publications.
Punishment: The paper is automatic rejected and the authors are forbidden to submit further articles to the journal.

Retraction

The articles published in Pharmaceutical and Biomedical Sciences Journal (PBSJ)  will be considered to retract in the publication if:
1. It has a clear evidence that the findings are unreliable, either as a result of misconduct (e.g. data fabrication) or honest error (e.g. miscalculation or experimental error).

2. The findings have previously been published elsewhere without proper crossreferencing, permission or justification (i.e. cases of redundant publication).

3. It contains plagiarism.

4. It reports an unethical research.

The mechanism of retraction follows the Retraction Guidelines of Committee on Publication Ethics (COPE) which can be accessed at https://publicationethics.org/files/retraction%20guidelines.pdf.

Erratum and Corrigendum

Policy and best practice: errata & corrigenda

For the purposes of this document the term Editorencompasses all Editor title variations and is limited to those that have final acceptance responsibility.

Changes/Additions to accepted articles

All content of published articles are subject to the editorial review process, organized by and under the auspices of the Editor. Should the authors wish to add to their article after acceptance, they must submit a request the Editor and the new content will be reviewed.

  • If the new material is additional to the accepted article, it must be submitted for peer review as a new manuscript, referring back to the original;
  • If the new material should replace the original content of the accepted article, the Editor may consider the publication of an Erratum or a Corrigendum.

Erratum

An erratum refers to a correction of errors introduced to the article by the publisher.

All publisher-introduced changes are highlighted to the author at the proof stage and any errors are ideally identified by the author and corrected by the publisher before final publication.

Corrigendum

A corrigendum refers to a change to their article that the author wishes to publish at any time after acceptance. Authors should contact the Editor of the journal, who will determine the impact of the change and decide on the appropriate course of action. The Journal of Society and  will only instigate a corrigendum to a published article after receiving approval and instructions from the Editor.

Direct Marketing

The  Pharmaceutical and Biomedical Sciences Journal (PBSJ)  carries out marketing through the journal website and various social media. Our marketing process unobtrusive.

Revenue Sources

The Pharmaceutical and Biomedical Sciences Journal (PBSJ) regularly publishes articles which are funded from funds from the  Pharmacy Department, Faculty of Health Sciences, UIN Syarif Hidayatullah Jakarta, Indonesia

Advertising

The  Pharmaceutical and Biomedical Sciences Journal (PBSJ) does not provide or offer services related to advertising, publishing and education.

Ownership and Management

The Pharmaceutical and Biomedical Sciences Journal (PBSJ)  is owned by ‘Pharmacy Department, Faculty of Health Sciences, UIN Syarif Hidayatullah Jakarta, Indonesia. The journal is managed by a dedicated team of staff under the guidance of the editorial and advisory board. For more information - On the editorial board, please visit  https://journal.uinjkt.ac.id/index.php/pbsj/about/editorialTeam

License

Pharmaceutical and Biomedical Sciences Journal (PBSJ) have CC-BY-SA or an equivalent license as the optimal license for the publication, distribution, use, and reuse of scholarly work.

In developing strategy and setting priorities, Pharmaceutical and Biomedical Sciences Journal (PBSJ) recognize that free access is better than priced access, libre access is better than free access, and libre under CC-BY-SA or the equivalent is better than libre under more restrictive open licenses. We should achieve what we can when we can. We should not delay achieving free in order to achieve libre, and we should not stop with free when we can achieve libre.

Creative Commons License

Pharmaceutical and Biomedical Sciences Journal (PBSJ) is licensed under a Creative Commons Attribution 4.0 International License

You are free to:

  • Adapt ” remix, transform, and build upon the material for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.